Department of Radiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9085, USA.
Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abdom Radiol (NY). 2020 Jan;45(1):177-187. doi: 10.1007/s00261-019-02133-w.
To determine the prevalence and clinical significance of discordant LI-RADS (Liver Imaging Reporting and Data System) liver observations on multiphase contrast-enhanced (MCE) magnetic resonance imaging (MRI) in patients with cirrhosis.
This cross-sectional study included 93 cirrhosis patients who underwent 1.5 or 3 T MCE MRI for evaluation of hepatocellular carcinoma (HCC). Two abdominal radiologists independently reviewed T1-, T2-, diffusion-weighted unenhanced images as well as MCE T1-weighted fat-suppressed images and reported liver observations using LI-RADS. Concordance were recorded for detection (co-detected by both radiologists or not), size category (< 10; 10-19; ≥ 20 mm), and LI-RADS category assignment as reportable (LR-3/4/5/M) and actionable (LR-4/5/M). The overall concordance (i.e., concordant in detection, size, and LR-category) was calculated with 95% confidence interval [CI], and separately for detection, size, and LR-category. Clinical significance of discordance was assessed as impact on follow-up imaging, referral for biopsy, liver transplant eligibility, or treatment modality.
Reportable and actionable observations were overall concordant between two radiologists only in 32.3% [24.6, 41.0] and 40.1% [29.5, 51.5] of cases, respectively. Poor overall concordance was related to detection concordance of 52.0% [44.3, 59.5] and 62.5% [52.3, 71.8], as well as LR-category concordance of 73.7% [61.6, 83.1] and 70.9% [57.3, 81.6], for reportable and actionable observations, respectively. Discordant LI-RADS observations would have impacted clinical management in 30 subjects (43.5%), most (66.7%) of whom were due to discordant detection.
Discordant MRI LI-RADS observations are common in patients with cirrhosis and may have potential implications for patient management.
确定肝硬化患者多期对比增强(MCE)磁共振成像(MRI)上 LI-RADS(肝脏成像报告和数据系统)肝脏观察结果不一致的患病率和临床意义。
本横断面研究纳入了 93 例因肝细胞癌(HCC)评估而行 1.5 或 3 T MCE MRI 的肝硬化患者。两名腹部放射科医生独立评估 T1、T2、弥散加权未增强图像以及 MCE T1 加权脂肪抑制图像,并使用 LI-RADS 报告肝脏观察结果。记录检测结果的一致性(两名放射科医生共同检测或未共同检测)、大小类别(<10;10-19;≥20mm)以及 LI-RADS 类别赋值(可报告[LR-3/4/5/M]和可行动[LR-4/5/M])。计算 95%置信区间(CI)的总体一致性(即检测、大小和 LR 类别均一致),并分别对检测、大小和 LR 类别进行一致性评估。评估不一致的临床意义为对随访影像学、活检转诊、肝移植资格或治疗方式的影响。
在报告和可行动观察中,两名放射科医生之间仅在 32.3%[24.6,41.0]和 40.1%[29.5,51.5]的病例中总体一致。总体一致性较差与检测一致性(52.0%[44.3,59.5]和 62.5%[52.3,71.8])以及 LR 类别一致性(报告和可行动观察分别为 73.7%[61.6,83.1]和 70.9%[57.3,81.6])相关。30 例(43.5%)患者的 LI-RADS 观察结果不一致可能会影响临床管理,其中大多数(66.7%)是由于检测不一致所致。
肝硬化患者的 MRI LI-RADS 观察结果不一致较为常见,可能对患者管理产生潜在影响。